Viewing Study NCT02817594


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-04-03 @ 4:31 PM
Study NCT ID: NCT02817594
Status: COMPLETED
Last Update Posted: 2019-05-17
First Post: 2016-06-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-01-20
Start Date Type: ACTUAL
Primary Completion Date: 2018-03-07
Primary Completion Date Type: ACTUAL
Completion Date: 2018-03-07
Completion Date Type: ACTUAL
First Submit Date: 2016-06-27
First Submit QC Date: None
Study First Post Date: 2016-06-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-02-06
Results First Submit QC Date: None
Results First Post Date: 2019-05-17
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-05-15
Last Update Post Date: 2019-05-17
Last Update Post Date Type: ACTUAL